A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this study is to learn about a low sulfur diet in patients with Crohn's disease. Study participants will be randomized to receive a low sulfur diet or usual diet for 8 weeks. Participants will work with study nutritionists and receive dietary educational materials. Participants will attend 2 in-person visits as well as 6 phone visits during the study. In addition, subjects will undergo testing, including a test to measure rectal sensation, a test to look for small intestinal bacterial overgrowth, and a test to measure leaky gut.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2023
CompletedStudy Start
First participant enrolled
December 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
January 15, 2026
January 1, 2026
3.1 years
April 25, 2023
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Dietary Protein Intake for both groups as assessed by 24 hour diet recall
Dietary protein intake (animal-based) as assessed by 24 hour diet recall
8 weeks
Dietary Protein Intake as assessed by 24 hour diet recall
Dietary protein intake (animal-based) as assessed by 24 hour diet recall. This is for the group that voluntarily goes on the low sulfur diet after standard of care arm is completed.
Approximately 16 weeks
Change in 24 hour urinary sulfate
Change in 24 hour urinary sulfate level from baseline
8 weeks
Change in 24 hour urinary sulfate
Change in 24 hour urinary sulfate level from baseline. This is for the group that voluntarily goes on the low sulfur diet after standard of care arm is completed
Approximately 16 weeks
Secondary Outcomes (4)
Tolerability of Low Sulfur Diet based on the Visual Analog Scale (VAS)
Week 4
Tolerability of Low Sulfur Diet based on the Visual Analog Scale (VAS)
Approximately week 12
Tolerability of Low Sulfur Diet based on the Visual Analog Scale (VAS)
Week 8
Tolerability of Low Sulfur Diet based on the Visual Analog Scale (VAS)
Approximately 16 weeks
Study Arms (2)
Low Sulfur Diet
EXPERIMENTALParticipants in this group will follow a low sulfur diet. This diet decreases the amount of animal products (including meat, dairy, and eggs) as well as sulfur additives in the diet. The main types of foods in the low sulfur diet include fruits, vegetables, whole grains, nuts, seeds, and soy products.
Usual Diet
ACTIVE COMPARATORParticipants in this group will follow a standard of care usual diet for 8 weeks.
Interventions
Subjects will be placed on a low sulfur diet for 8 weeks with the support of a nutritionist. In addition, participants will be asked to complete: surveys, lactulose-mannitol test, glucose hydrogen breath test, blood samples, visceral sensation test, 24-hour urine sample for sulfate level, provide stool samples, optional colonoscopy.
Subjects will continue on their usual diet for 8 weeks. At the end of 8 weeks, if participants are interested, they will be offered treatment with low sulfur diet for 8 weeks with the support of a nutritionist. In addition, participants will be asked to complete: surveys, lactulose-mannitol test, glucose hydrogen breath test, blood samples, visceral sensation test, 24-hour urine sample for sulfate level, provide stool samples, optional colonoscopy.
Eligibility Criteria
You may qualify if:
- Prior diagnosis of Crohn's disease based on endoscopic, radiographic, and/or histologic findings
- Quiescent Crohn's disease as defined by fecal calprotectin level less than 150 micrograms/gram (mcg/g) stool and/or absence of inflammation on colonoscopy within 30 and 90 days, respectively, of enrollment
- Persistent symptoms will be defined by abdominal pain and/or diarrhea T-scores greater than or equal to 55 by the National Institutes of Health (NIH) Patient-Reported outcomes measurement information system Gastrointestinal scale (PROMIS-GI)
You may not qualify if:
- Prior total colectomy
- Presence of an end ileostomy or colostomy in place
- Changes in immunosuppressive medications within the past 4 weeks
- Use of antibiotics or probiotics within the past 4 weeks
- Active or suspected stricture/stenosis of the GI tract
- Habitual vegetarian or vegan diet
- Active or suspected gastrointestinal stricture or stenosis
- Unable or unwilling to follow a low sulfur diet
- Patients who are underweight as defined by BMI \< 18.5 kg/m2 or have significant unintentional weight loss as defined by \>7.5% body weight in the past 3 months
- Currently pregnant, breastfeeding, and/or unwillingness/inability to use contraception start of the study until the last 13C-mannitol:lactulose test is complete. Sexually active male participants and/or their female partners of reproductive potential must agree to use effective contraception from the start of the study and until the last 13C-mannitol:lactulose test is complete. Women who are breastfeeding must stop breastfeeding during and for at least 12 hours after consuming the 13C-mannitol:lactulose test. Breastfeeding women must pump and dispose of the breastmilk during this time period
- Subjects must agree to not donate sperm or ova (eggs) or breast milk from the start of the study until the last 13C-mannitol:lactulose test is complete.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allen Lee, MD, MS
Assistant Professor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 25, 2023
First Posted
May 8, 2023
Study Start
December 12, 2023
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
April 30, 2027
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
To be determined